Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Apr 01 '24 | Option Exercise | 0.00 | 3,306 | 0 | 6,532 | Apr 02 06:45 PM | Lenkowsky Adam | EVP, Chief Commercial Officer | Mar 10 '24 | Option Exercise | 0.00 | 15,016 | 0 | 13,859 | Mar 12 09:54 PM | LEUNG SANDRA | EVP, General Counsel | Mar 10 '24 | Option Exercise | 0.00 | 46,784 | 0 | 371,312 | Mar 12 09:43 PM | Plenge Robert M | EVP, Chief Research Officer | Mar 10 '24 | Option Exercise | 0.00 | 9,143 | 0 | 15,182 | Mar 12 09:21 PM | Poole Ahn Amanda | EVP, Chief Human Resources | Mar 10 '24 | Option Exercise | 0.00 | 5,458 | 0 | 4,841 | Mar 12 09:11 PM | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Mar 10 '24 | Option Exercise | 0.00 | 38,388 | 0 | 80,256 | Mar 12 08:40 PM | Holzer Phil M | SVP and Controller | Mar 10 '24 | Option Exercise | 0.00 | 5,520 | 0 | 14,916 | Mar 12 08:31 PM | Hoch Lynelle | President, Cell Therapy Org. | Mar 10 '24 | Option Exercise | 0.00 | 4,351 | 0 | 3,781 | Mar 12 08:01 PM | Gallman Cari | EVP, Corporate Affairs | Mar 10 '24 | Option Exercise | 0.00 | 2,761 | 0 | 2,655 | Mar 12 08:00 PM | BOERNER CHRISTOPHER S. | Chief Executive Officer | Mar 10 '24 | Option Exercise | 0.00 | 54,638 | 0 | 129,769 | Mar 12 07:58 PM | Elkins David V | EVP, Chief Financial Officer | Mar 10 '24 | Option Exercise | 0.00 | 64,326 | 0 | 225,111 | Mar 12 05:43 PM | Caforio Giovanni | Executive Chair of the Board | Mar 10 '24 | Option Exercise | 0.00 | 190,130 | 0 | 529,662 | Mar 12 05:42 PM | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Feb 01 '24 | Option Exercise | 0.00 | 2,543 | 0 | 6,040 | Feb 05 07:10 PM | BOERNER CHRISTOPHER S. | Chief Executive Officer | Dec 05 '23 | Buy | 49.78 | 2,000 | 99,560 | 82,672 | Dec 07 06:06 PM | Plenge Robert M | EVP, Chief Research Officer | Dec 02 '23 | Option Exercise | 0.00 | 616 | 0 | 7,200 | Dec 05 06:23 PM | Elkins David V | EVP, Chief Financial Officer | Dec 02 '23 | Option Exercise | 0.00 | 8,792 | 0 | 172,342 | Dec 05 06:22 PM | BOERNER CHRISTOPHER S. | Chief Executive Officer | Dec 02 '23 | Option Exercise | 0.00 | 2,638 | 0 | 82,022 | Dec 05 06:21 PM | BOERNER CHRISTOPHER S. | Chief Executive Officer | Nov 28 '23 | Buy | 48.86 | 3,071 | 150,049 | 79,384 | Nov 30 06:32 PM | Samuels Theodore R. II | Director | Nov 20 '23 | Buy | 49.81 | 8,500 | 423,385 | 35,500 | Nov 21 07:01 PM | Powell Ann | EVP, Chief Human Resources | Aug 24 '23 | Sale | 61.25 | 17,986 | 1,101,642 | 27,868 | Aug 28 05:28 PM | Plenge Robert M | EVP, Chief Research Officer | Aug 03 '23 | Sale | 61.14 | 732 | 44,754 | 6,584 | Aug 07 05:24 PM | Weese Michelle | EVP, Corporate Affairs | Jul 01 '23 | Option Exercise | 0.00 | 1,885 | 0 | 4,135 | Jul 05 05:26 PM | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Jul 01 '23 | Option Exercise | 0.00 | 9,357 | 0 | 52,032 | Jul 05 05:23 PM | Lenkowsky Adam | EVP, Chief Commercial Officer | Jun 03 '23 | Option Exercise | 0.00 | 1,077 | 0 | 1,077 | Jun 06 07:39 PM |
|